Successfully Treated Basal Cell Carcinoma with Mohs Surgery, Diagnosing with Dermoscopy as a Primary Diagnostic Tool without Preoperative Punch Biopsy: A Report of Two Cases
- Author:
Jaeyeong JEONG
1
;
Taewoong SEUL
;
Byeong-geun PARK
;
Haneul OH
;
Il-Hwan KIM
Author Information
1. Department of Dermatology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea
- Publication Type:Case Report
- From:Korean Journal of Dermatology
2021;59(7):555-559
- CountryRepublic of Korea
- Language:English
-
Abstract:
Basal cell carcinoma (BCC) is the most common malignant tumor of the skin, with a nearly 2-fold increase in incidence rates over the last two decades. A punch biopsy is considered the primary diagnostic tool for BCC; however, recent studies have reported favorable sensitivity and specificity of dermoscopy as a diagnostic tool for this malignancy. Diagnosis of BCC using the “Menzies criteria” was associated with high sensitivity, and surgery performed immediately after clinico-dermoscopic diagnosis was associated with a high positive predictive value.Therefore, in view of the high diagnostic accuracy, positive predictive value, and cost-effectiveness, direct surgical treatment without preoperative biopsy may serve as a primary therapeutic strategy for BCCs that present with typical clinico-dermoscopic features. We report two cases of BCC in patients who underwent successful Mohs microsurgery without preoperative biopsy, using dermoscopy as a primary diagnostic tool.